[Zurück]
 
Bitte auswählen
Jahr
Details
Sprache
Sortierung
Ausgabe
neu: RTF !
 Forschungsbericht für das Jahr 2014

Wissenschaftliche Publikationen

Originalarbeiten in wissenschaftlichen Fachzeitschriften:
  • Bleses D, Højen A, Dybdal L, Dale P, Justice L, Piasta S, Markussen-Brown J, Clausen M, Haghish EF, Ari BA, Andersen MK, Vach W: A Randomized Controlled Trial of a Large Scale Systematic and Explicit Language and Literacy Intervention in Danish Daycares: The SPELL Study. [Study Protocol]. British Journal of Education, Society and Behavioural Science, 2014; 4 (11): 1504-1524. : http://dx.doi.org/10.9734/BJESBS/2014/11691
  • Böhringer D, Vach W, Hagenlocher K, Eberwein P, Maier P, Reinhard T: Are entry criteria for cataract surgery justified? Plos One, 2014; 9 (11) (online): e112819. : http://dx.doi.org/10.1371/journal.pone.0112819
  • Borde JP, Batin N, Rieg S, Feik R, Reimling C, Kern WV, de With K, Hübner J, Ruhnke M, Kaier K: Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection, 2014; 42 (4): 713-719. : http://dx.doi.org/10.1007/s15010-014-0633-1
  • Borde JP, Kaier K, Steib-Bauert M, Vach W, Geibel-Zehender A, Busch H, Bertz H, Hug M, de With K *, Kern WV *: Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. Bmc Infect Dis, 2014; 14 (online): 201. : http://dx.doi.org/10.1186/1471-2334-14-201
  • Gladstone BP, Vach W: Choice of Non-Inferiority (NI) Margins Does Not Protect against Degradation of Treatment Effects on an Average - An Observational Study of Registered and Published NI Trials. Plos One, 2014; 9 (7) (online): e103616. : http://dx.doi.org/10.1371/journal.pone.0103616
  • Haghish EF, Heydari A, Pfuhl G, Biegler R, Teymoori A: The Scale of Ethical Attitude toward Ethnic Humor (EATEH): Development, Reliability, and Validity. Asian Social Science, 2014; 10 (1): 74-85. : http://dx.doi.org/10.5539/ass.v10n1p74
  • Heydari A, Teymoori A, Haghish EF, Mohamadi B: Influential factors on ethnocentrism: The effect of socioeconomic status, anomie, and authoritarianism. Soc Sci Inform, 2014; 53 (2): 240-254. : http://dx.doi.org/10.1177/0539018413517521
  • Jabbarli R, Shah M, Taschner C, Kaier K, Hippchen B, Van Velthoven V: Clinical utility and cost-effectiveness of CT-angiography in the diagnosis of nontraumatic subarachnoid hemorrhage. Neuroradiology, 2014; 56 (10): 817-824. : http://dx.doi.org/10.1007/s00234-014-1406-3
  • Jilg CA, Schultze-Seemann W, Drendel V, Vach W, Wieser G, Krauss T, Jandausch A, Hölz S, Henne K, Reske SN, Grosu AL, Weber WA, Rischke HC: Detection of Lymph Node Metastasis in Patients with Nodal Prostate Cancer Relapse Using F/C-Choline Positron Emission Tomography/Computerized Tomography. J Urology, 2014; 192 (1): 103-111. : http://dx.doi.org/10.1016/j.juro.2013.12.054
  • Jones A, Gladstone BP, Lübeck M, Lindekilde N, Upton D, Vach W: Motivational interventions in the management of HbA1c levels: A systematic review and meta-analysis. Prim Care Diabetes, 2014; 8 (2): 91-100. : http://dx.doi.org/10.1016/j.pcd.2014.01.009
  • Kaier K, Lambert ML, Frank UK, Vach W, Wolkewitz M, Tacconelli E, Rello J, Theuretzbacher U, Martin M: Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide. Bmc Infect Dis, 2014; 14 (online): 199. : http://dx.doi.org/10.1186/1471-2334-14-199
  • Kakourou A, Vach W, Martens B: Combination Approaches Improve Predictive Performance of Diagnostic rules for Mass-Spectrometry Proteomic Data. J Comput Biol, 2014; 21 (12): 898-914. : http://dx.doi.org/10.1089/cmb.2014.0125
  • Kongsted A, Vach W, Axo M, Bech RN, Hestbaek L: Expectation of recovery from low back pain- A longitudinal cohort study investigating patient characteristics related to expectations and the association between expectations and 3-month outcome. Spine, 2014; 39: 81-90. : http://dx.doi.org/10.1097/BRS.0000000000000059
  • Peter HH, Goldacker S, Haraldseide J, Großmann K, Gross W, Warnatz K, Grimbacher B, Rusch S, Nieters A, Vach W: Construction and Clinical Validation of a Questionnaire-based Risk Score to Identify Patients Suffering from Immunodeficiency or Systemic Autoimmunity. British Journal of Medicine & Medical Research, 2014; 4 (29): 4751-4769. : http://dx.doi.org/10.9734/BJMMR/2014/10823
  • Peter J, Abdulkadir A, Kaller C, Kümmerer D, Hüll M, Vach W, Klöppel S: Subgroups of Alzheimer's Disease: Stability of Empirical Clusters Over Time. J Alzheimers Dis, 2014; 42 (2): 651-661. : http://dx.doi.org/10.3233/JAD-140261
  • Rischke HC, Beck T, Vach W, Wieser G, Grosu AL, Schultze-Seemann W, Meyer PT, Jilg CA: Furosemide diminishes 18F-fluoroethylcholine uptake in prostate cancer in vivo. Eur J Nucl Med Mol I, 2014; 41 (11): 2074-2082. : http://dx.doi.org/10.1007/s00259-014-2829-0
  • Schwander B, Banz K, Kaier K, Walzer S: Evaluation of a possible predictor for Federal Joint Committee decisions on early benefit assessments according to the German act on the reform of the market for medicinal products. Health Policy, 2014; 117 (3): 334-344. : http://dx.doi.org/10.1016/j.healthpol.2014.07.002
  • Siepe B, Hoilund-Carlsen PF, Gerke O, Weber WA, Motschall E, Vach W: The Move from Accuracy Studies to Randomized Trials in PET: Current Status and Future Directions. J Nucl Med, 2014; 55 (8): 1228-1234. : http://dx.doi.org/10.2967/jnumed.113.127076
  • Vach W: Quantifizierung des Ausmaßes des Zusatznutzens von neuen Arzneimitteln: "gering" – "beträchtlich" – "erheblich" – 6 Anmerkungen aus der Sicht eines Biometrikers. [Quantifying the Additional Clinical Benefit of New Medicines: Little – Considerable – Significant – 6 Remarks from a biometrician's Point of View]. Gesundheitswesen, 2014; 76 (11): 757-762. : http://dx.doi.org/ 10.1055/s-0033-1363682
Kurzbeiträge / short communications:
Konferenzbeiträge:
  • Droeschel D, Kaier K, Walzer S: The Clinical Evidence Base of Treatment Options in Alzheimer's Disease: a Systematic Literature Search. [Meeting Abstract PND11]. Value Health, 2014; 17 (7): A392 (ISPOR 17th Annual European Congress, Amsterdam 8.-12.11.2014). : http://dx.doi.org/10.1016/j.jval.2014.08.865
  • Gutmann A, Sorg S, von zur Mühlen C, Kaier K, Moser M, Blanke P, Beyersdorf F, Bode C, Zehender M, Reinöhl J: Interventionelle, chirurgische und medikamentöse Therapie der Aortenklappenstenose – Mortalität und Lebensqualität bei Hochrisiko-Patienten. Clin Res Cardiol, 2014; 103 Suppl. 1: P1716 (80. Jahrestagung der Deutschen Gesellschaft für Kardiologie in Mannheim, 23.-26.4.2014). : http://dx.doi.org/10.1007/s00392-014-1100-9 (download: http://www.abstractserver.de/dgk2014/ft/abstracts/P1716.HTM)
  • Kaier K, Gutmann A, Sorg S, Beyersdorf F, Vach W, Zehender M, Bode C, Reinöhl J: The Additional Costs Of Clinical Complications In Patients Undergoing Transcatheter Aortic Valve Replacement In The German Health Care System. Abstract No. PCV3. Value Health, 2014; 17 (7): A473 (ISPOR 17th Annual European Congress, Amsterdam 8.-12.11.2014.). : http://dx.doi.org/10.1016/j.jval.2014.08.1347
  • Kaier K, Gutmann A, Vach W, Sorg S, von zur Mühlen C, Geibel-Zehender A, Beyersdorf F, Bode C, Zehender M, Reinöhl J: Clinical decision-making among patients with symptomatic aortic valve stenosis – A look behind the curtain. Clin Res Cardiol, 2014; 103 Suppl. 1: P1726 (80. Jahrestagung der Deutschen Gesellschaft für Kardiologie in Mannheim, 23.-26.4.2014). : http://dx.doi.org/10.1007/s00392-014-1100-9 (download: http://www.abstractserver.de/dgk2014/ft/abstracts/P1726.HTM)
  • Pandurevic M, Selder R, Möller M, Kleber M, Pantic M, Waldschmidt J, Herget G, Henne K, Hauschild O, May A, von Bubnoff N, Duyster J, Vach W, Wäsch R, Engelhardt M: Current results on patient (pt), referring physician and participant satisfaction concerning the interdisciplinary Comprehensive Cancer Center (CCCF) Tumor Board (TB) 'Multiple Myeloma' (MM). Oncology Research and Treatment, 2014; 37 Suppl. 5: 288 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg, 10.-14. Oktober 2014. Meeting Abstract: P865 .). : http://dx.doi.org/10.1159/000368945
  • Reinöhl J, Kaier K, Gutmann A, Sorg S, von zur Mühlen C, Moser M, Geibel-Zehender A, Blanke P, Beyersdorf F, Bode C, Zehender M: Resource utilization and risk prediction in the treatment of symptomatic aortic valve stenosis. Clin Res Cardiol, 2014; 103 Suppl. 1: P1688 (80. Jahrestagung der Deutschen Gesellschaft für Kardiologie in Mannheim, 23.-26.4.2014). : http://dx.doi.org/10.1007/s00392-014-1100-9 (download: http://www.abstractserver.de/dgk2014/ft/abstracts/P1688.HTM)
  • Schwander B, Banz K, Kaier K, Walzer S: Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceuticals. Abstract No PHP199. Value Health, 2014; 17 (7): A437 (ISPOR 17th Annual European Congress, Amsterdam 8.-12.11.2014). : http://dx.doi.org/10.1016/j.jval.2014.08.1135
  • Selder R, Pandurevic M, Möller MD, Waldschmidt J, Pantic M, Herget GW, Henne K, May A, Kleber M, Udi J, Ihorst G, Bredenkamp R, Vach W, Duyster J, Wäsch R, Engelhardt M: First Results of the Interdisciplinary Comprehensive Cancer Center Freiburg (CCCF) Tumor Board (TB) Multiple Myeloma (MM) Assessing TB-Questions, TB-Advice Adherence, TB-Satisfaction of Patients, Participants and Referring Physicians, Inclusion of Difficult-to-Treat-MM Pts in Clinical Trials (CT) and Patient Outcome. Blood, 2014; 124 (21) (56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, Dec 06-09, 2014). : http://www.bloodjournal.org/content/124/21/2635
  • Selder RM, Möller MD, Pandurevic M, Kleber M, Waldschmidt J, Herget GW, Henne K, Hauschild O, May AM, Pantic M, von Bubnoff N, Duyster J, Vach W, Wäsch R, Engelhardt M: First results of the interdisciplinary Comprehensive Cancer Center Freiburg (CCCF) Tumor Board (TB)-'Multiple Myeloma' (MM) in terms of TB-questions, patient (pt) outcome, TB-advice adherence and suitability of difficult-to-treat-MM pts to include in clinical trials (CT). Oncology Research and Treatment, 2014; 37 Suppl. 5: 288 (Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg, 10.-14. Oktober 2014. Meeting Abstract: P864 .). : http://dx.doi.org/10.1159/000368945
  • Walzer S, Droeschel D, Kaier K: Health Economic Models in Alzheimer's Disease: A Critical Assessment. Abstract No. PRM81. Value Health, 2014; 17 (7): A557 (ISPOR 17th Annual European Congress, Amsterdam 8.-12.11.2014). : http://dx.doi.org/10.1016/j.jval.2014.08.1833
Sonstige Publikationen:
  • Hoilund-Carlsen PF, Gerke O, Vach W: Demonstrating the benefits of clinical nuclear imaging: is it time to add economic analysis? Eur J Nucl Med Mol I, 2014; 41 (9) : 1720-1722. : http://dx.doi.org/10.1007/s00259-014-2807-6